arrow
W

Wei Bai

East China Normal University
H指数:27
被引数:2,724

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sorafenib combined with transarterial chemoembolization compared with sorafenib alone in advanced hepatocellular carcinoma (SELECT): a multicenter, phase 3, randomized, controlled trial

索拉非尼联合经动脉化疗栓塞与索拉非尼单药治疗晚期肝细胞癌的比较(SELECT):一项多中心、III期、随机对照试验

2025-02-010
OAAI